BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 7114868)

  • 1. Methotrexate and etretinate as concurrent therapies in severe psoriasis.
    Vanderveen EE; Ellis CN; Campbell JP; Case PC; Voorhees JJ
    Arch Dermatol; 1982 Sep; 118(9):660-2. PubMed ID: 7114868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined treatment of severe forms of psoriasis using aromatic retinoid].
    Mashkilleĭson AL; Mashkilleĭson NA
    Vestn Dermatol Venerol; 1982 Sep; (9):42-5. PubMed ID: 7180191
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of RePUVA and aromatic retinoid Ro 10-9359 with methotrexate in severe forms of psoriasis].
    Mashkilleysson AL; Mashkilleysson NA
    Hautarzt; 1983 May; 34(5):229-30. PubMed ID: 6862887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent methotrexate and etretinate therapy for psoriasis.
    Adams JD
    Arch Dermatol; 1983 Oct; 119(10):793. PubMed ID: 6614945
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined oral retinoid and PUVA therapy in the treatment of psoriasis and psoriatic arthropathy (author's transl)].
    Thivolet J; Robart S; Vignon E
    Ann Dermatol Venereol; 1981; 108(2):131-7. PubMed ID: 6972721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of erythrodermic and pustulous psoriasis with a combination of methotrexate and etretinate].
    Allegue Rodriguez F; Sendagorta Gomendio E; Freire Murgueytio P; Moreno Izquierdo R; Ledo Pozueta A
    Med Cutan Ibero Lat Am; 1988; 16(1):43-9. PubMed ID: 2967409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
    Mahrle G; Meyer-Hamme S; Ippen H
    Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of retinoids in the treatment of psoriasis.
    Warren EW; Khanderia U
    Clin Pharm; 1989 May; 8(5):344-51. PubMed ID: 2663325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A three-year follow-up study of psoriasis patients treated with low dosages of etretinate orally and corticosteroids topically.
    Polano MK; van der Rhee HJ; van der Schroeff JG
    Acta Derm Venereol; 1982; 62(4):361-4. PubMed ID: 6183880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
    Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM
    Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate and etretinate in the treatment of psoriasis.
    Vanderveen EE; Ellis CN
    Arch Dermatol; 1984 Dec; 120(12):1555-6. PubMed ID: 6508327
    [No Abstract]   [Full Text] [Related]  

  • 12. Etretinate therapy improves psoriasis but elevates serum lipids.
    Cowart VS
    JAMA; 1982 May; 247(19):2647-8. PubMed ID: 7077753
    [No Abstract]   [Full Text] [Related]  

  • 13. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
    Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
    Dermatologica; 1982 Sep; 165(3):204-7. PubMed ID: 6751889
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
    Frati C; Bevilacqua L; Apostolico V
    Acta Derm Venereol Suppl (Stockh); 1994; 186():151-3. PubMed ID: 8073820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined methods including PUVA therapy in the treatment of psoriasis].
    Ruszczak Z; Kaszuba A; Trznadel-Budźko E; Prószyńska-Kuczyńska W; Drobnik G
    Przegl Dermatol; 1987; 74(6):449-53. PubMed ID: 3330248
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis.
    Giannetti A; Coppini M; Bertazzoni MG; Califano A; Altieri E; Pazzaglia A; Lega M; Lombardo M; Pelfini C; Veller Fornasa C; Rabbiosi G; Cespa M
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):91-5. PubMed ID: 10568486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New treatment of severe psoriasis-effects of the combination therapy of etretinate (Ro 10-9359) and PUVA or external corticoid (author's transl)].
    Sato A; Takahashi M; Seiji M
    Nihon Hifuka Gakkai Zasshi; 1981 Dec; 91(14):1803-15. PubMed ID: 6977667
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral retinoid for psoriasis. A report of a double blind study.
    Pettit JH
    Acta Derm Venereol Suppl (Stockh); 1979; 59(85):133-6. PubMed ID: 393035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psoriasis therapy with the aromatic retinoid Ro 10-9359 (Tigason)].
    Sönnichsen N; Harnack K; Barth J; Heilmann S; Jäger K; Metz D; Schiller F
    Z Hautkr; 1983 Sep; 58(17):1257-67. PubMed ID: 6636927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Side effects of oral retinoid Ro 10-9359 on the unaffected skin of psoriatic patients: retinoid dermatitis].
    Rüst O; Tufli T
    Schweiz Med Wochenschr; 1979 Dec; 109(48):1921-5. PubMed ID: 161414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.